Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins in Chronic Asthma
NCT00126048Phase 3Completed
- Sponsor
- University of Glasgow
- Start
- Jul 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atorvastatin in asthma (2 arms), sponsored by University of Glasgow. Primary endpoint: Peak Expiratory Flow Rate at 8 weeks. Started Jul 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00126048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126048.